HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 2 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $948,003 | -9.3% | 28,929 | -2.6% | 0.01% | -9.1% |
Q2 2023 | $1,045,495 | +5.4% | 29,710 | -2.2% | 0.01% | 0.0% |
Q1 2023 | $991,711 | -43.2% | 30,374 | -4.2% | 0.01% | -47.6% |
Q4 2022 | $1,746,119 | +24.0% | 31,690 | -0.3% | 0.02% | +16.7% |
Q3 2022 | $1,408,000 | -11.4% | 31,792 | -2.5% | 0.02% | -10.0% |
Q2 2022 | $1,590,000 | -1.2% | 32,594 | -1.4% | 0.02% | +11.1% |
Q1 2022 | $1,609,000 | – | 33,069 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |